Robert A. McCabe Jr., a director at National Health Investors Inc. (NASDAQ: NHI), executed a purchase of the company's common stock on June 15, 2026. The acquisition involved 890 shares bought at a price of $71.6485 per share, resulting in a total transaction value of $63,767. Following this purchase, Mr. McCabe Jr. directly holds 44,158.96 shares of National Health Investors common stock.
The timing of the acquisition is notable as NHI shares trade at $70.70, a level near its 52-week low of $67.94. According to InvestingPro analysis, the stock appears undervalued relative to its Fair Value. The company continues to offer investors a 5.1% dividend yield and has maintained dividend payments for 36 consecutive years, as noted in InvestingPro Tips. For more detailed insights into NHI's financial health and additional ProTips, investors can access the comprehensive Pro Research Report available exclusively on InvestingPro.
In other recent developments, National Health Investors Inc. reported strong first-quarter 2026 performance, exceeding both earnings and revenue expectations. The company achieved earnings per share of $0.82, slightly above the anticipated $0.8158, and reported revenue of $73.15 million, surpassing the forecast of $69.6 million. Additionally, Truist Securities adjusted its price target for National Health Investors, lowering it from $89 to $81, while maintaining a Buy rating on the stock. This adjustment followed the firm's revision of funds from operations estimates for 2026 and 2027, due to developments related to the company's NHC portfolio sale. The NHC portfolio sale was announced on April 21, 2026, and the company reported its first-quarter results on May 4, 2026. These recent developments reflect National Health Investors' ongoing financial and strategic activities.